TANGO THERAPEUTICS INCORPORATED (TNGX)

Revenue of $487.5 million, up 16% from $421.7 million in Q2/25Diluted earnings per share of $0.51, up 96% from $0.26 in Q2/25, including a 20 cent per share increase related to net foreign exchange gains in Q2/26 compared with losses in Q2/25Adjusted diluted earnings per share1 of $0.62, up ...

The average weekly price growth across all stocks in the @Biotechnology industry was -2.38%. For the same industry, the average monthly price growth was +2.73%, and the average quarterly price growth was +1869.71%. EXPO is expected to report earnings on Jul 30, 2026. TNGX is expected to report ...

Analog chip manufacturer Texas Instruments (NASDAQ:TXN) will be reporting results this Wednesday after the bell. Here’s what to expect.

U.S. stocks mixed as investors eye earnings season for next major market catalyst · Selloff of U.S. memory stocks creates a compelling entry point: analyst · Top 3 AI stocks to buy as Kimi K3 reshapes chip design ... Investing.com - Mizuho raised its price target on Tango Therapeutics Inc. (NASDAQ:T…

Tango Therapeutics Inc. (NASDAQ:TNGX) is one of the 10 affordable biotech stocks to buy right now. On June 29, Canaccord Genuity increased its target price on Tango Therapeutics Inc. (NASDAQ:TNGX) from $42 to $46, resulting in more than 53% upside potential. The firm kept a Buy rating on the ...